ScanSource, Inc. filings document the reporting obligations of a Nasdaq-listed technology distributor with common stock traded under SCSC. Recent Form 8-K disclosures cover quarterly and fiscal-year operating results, earnings exhibits, Regulation FD materials, executive appointments, board leadership updates and changes in the company’s independent registered public accounting firm.
The company’s proxy materials provide governance and shareholder-meeting disclosures, while periodic reporting referenced in its earnings filings frames results against annual and quarterly reports. These records center on operating performance, financial presentation, corporate governance, auditor oversight and the capital-market status of ScanSource common stock.
Scansource, Inc. (SCSC) – Form 4 insider transaction
On 20 June 2025, Rachel Hayden, Senior Executive Vice President & Chief Information Officer of Scansource, Inc., filed a Form 4 disclosing a single open-market sale (Transaction Code “S”) of the company’s common stock executed under a Rule 10b5-1 sales plan adopted 20 March 2025. Hayden disposed of 6,738 shares at an average price of $41.27 per share, representing gross proceeds of roughly $278 k. Following the sale, the executive retains direct beneficial ownership of 13,174 shares of Scansource common stock.
No derivative securities were reported and no other transactions were disclosed in the filing. The transaction does not alter Hayden’s officer status, and there is no indication that the reporting person is no longer subject to Section 16 obligations; the filing was made solely to report the change in beneficial ownership.
The use of a pre-arranged 10b5-1 plan indicates the transaction was scheduled in advance, providing an affirmative defense against insider-trading allegations.
ScanSource, Inc. (SCSC) – Form 144 filing overview
This Form 144 is a notice of a proposed insider sale of 6,738 common shares of ScanSource, Inc., to be executed through Merrill Lynch, Atlanta. The shares have an aggregate market value of $278,077.26, or roughly 0.03 % of the company’s 22.6 million shares outstanding. The transaction is scheduled for 20 June 2025 on the NASDAQ.
The seller acquired the shares through multiple equity-compensation events, including restricted stock unit (RSU) and performance stock unit (PSU) vestings dated between August 2023 and June 2025. No other sales have been reported by this person in the past three months, and no information is provided that would indicate a Rule 10b5-1 trading plan.
The filing is strictly a notice; it does not confirm that the sale has occurred, nor does it disclose the insider’s name, position, or additional context. Given the modest size of the trade relative to shares outstanding and the absence of additional insider activity, the market impact is expected to be limited, though investors may monitor further filings for trend confirmation.